Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$13.13 - $14.17 $223 - $240
17 Added 2.31%
754 $10,000
Q1 2023

Apr 20, 2023

BUY
$13.37 - $14.94 $240 - $268
18 Added 2.5%
737 $10,000
Q4 2022

Jan 27, 2023

BUY
$13.55 - $15.23 $203 - $228
15 Added 2.13%
719 $0
Q3 2022

Oct 19, 2022

BUY
$13.39 - $16.31 $200 - $244
15 Added 2.18%
704 $10,000
Q2 2022

Jul 28, 2022

BUY
$13.11 - $17.02 $222 - $289
17 Added 2.53%
689 $10,000
Q1 2022

May 03, 2022

BUY
$15.35 - $19.29 $245 - $308
16 Added 2.44%
672 $11,000
Q4 2021

Jan 24, 2022

BUY
$18.5 - $21.59 $259 - $302
14 Added 2.18%
656 $13,000
Q3 2021

Nov 09, 2021

BUY
$20.27 - $22.67 $243 - $272
12 Added 1.9%
642 $13,000
Q2 2021

Aug 17, 2021

BUY
$19.14 - $21.44 $12,058 - $13,507
630 New
630 $13,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track West Branch Capital LLC Portfolio

Follow West Branch Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.